Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness (ARCMT2K or CMT4C4) is a severe early-onset form of axonal CMT peripheral sensorimotor polyneuropathy.
Features include very common findings: Peripheral axonal degeneration, Impaired vibratory sensation, Skeletal muscle atrophy, and Axonal loss and others; and common findings: Abnormality of the vertebral column, Reduced tendon reflexes, Flexion contracture, and Vocal cord paresis and others. 43 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 15 | Distal muscle weakness, Proximal muscle weakness, Skeletal muscle atrophy |
Arms and legs | 7 | Split hand, Distal upper limb muscle weakness, Proximal lower limb muscle weakness |
Brain and nerves | 4 | Nerve damage affecting sensation and movement (sensorimotor neuropathy), Chronic axonal neuropathy, Unsteady gait |
Bones and joints | 3 | Kyphoscoliosis, Skeletal muscle atrophy, Abnormality of the vertebral column |
GDAP1 encodes ganglioside induced differentiation associated protein 1 (358 aa). Regulates the mitochondrial network by promoting mitochondrial fission Highest expression in Brain Cerebellar Hemisphere (80.1 TPM) and Brain Frontal Cortex BA9 (56.7 TPM).
Charcot-Marie-Tooth disease axonal type 2K is associated with mutations in the GDAP1 gene on chromosome 8.
The GDAP1 protein participates in Class I Peroxisomal Membrane Proteins pathway.
GDAP1 is classified as a druggable target with score 0.0.
Genetic testing for GDAP1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 14 very common features, 16 common features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Charcot-Marie-Tooth disease axonal type 2K.
2 publications have been identified in PubMed for Charcot-Marie-Tooth disease axonal type 2K. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Ravanbod M (2025). [PMID: 40711989](https://pubmed.ncbi.nlm.nih.gov/40711989/). *J Peripher Nerv Syst*. [Review / Meta-Analysis]
Borisova NR (2025). [PMID: 41354077](https://pubmed.ncbi.nlm.nih.gov/41354077/). *Biochemistry (Mosc)*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 4:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease axonal type 2K